Table 2. Age and gender stratified by regimen, either 2 months or 4(+) months of kanamycin in 790 RR-TB patients treated with a gatifloxacin-based shorter treatment regimen in Bangladesh.

	Total		Kanamycin during the intensive phase
			4(+) months		2 months
	N	%	N	%	N	%	p-value
Total	790		738		52
Sex							0.1
Female	243	30.8	222	30.1	21	40.4
Male	547	69.2	516	69.9	31	59.6
Age group							0.1
< = 18 years	76	9.6	68	9.2	8	15.4
>18–35 years	409	51.8	378	51.2	31	59.6
>35–50 years	207	26.2	199	27	8	15.4
>50 years	98	12.4	93	12.6	5	9.6